This is an invitation to come to a public lecture in Wellington on November 17th to be given by Dr John Wyeth, Medical Director PHARMAC, on biosimilars.
Biosimilars are copies of biologic drugs which include infliximab (Remicade), adalimumab (Humira), etanercept (Enbrel) and trastuzumab (Herceptin) that are made by other pharmaceutical companies once the patent on the original brand has expired. Clinical trials are conducted with biosimilar medicines to demonstrate they have comparable quality, safety and effectiveness to an approved biologic medicine. Biosimilars may offer PHARMAC the opportunity to increase competition for biologics reducing their cost and improving access for patients to these important medicines.
PHARMAC as NZ’s central drug funding agency uses various methods to increase competition and reduce costs, one method is sole supply tendering which can lead to a brand switch for patients. Whilst this is common for small molecule medicines, where copies are known as generics, brand switching in biologics is new and may be more complex.
Recently a biosimilar infliximab was approved by regulatory authorities overseas and is it undergoing evaluation by the NZ regulator Medsafe.
Clinical trials of biosimilar infliximab show that it has comparable safety and effectiveness to Remicade in arthritis conditions but trials have not been done in inflammatory bowel diseases (IBDs). PHARMAC recently initiated a competitive process for this treatment which if implemented could lead to a brand switch for all patients, including those with IBDs. PHARMACs view on this and other biosimilar issues will be discussed.
This meeting will be of interest to clinicians and to patients on this medicine and others with autoimmune conditions (such as arthritis) on other biologics for which biosimilars are being developed.
Crohn’s & Colitis NZ is hosting the event on 17th November at the Medical School, Newtown at 7pm.
Admission is by koha, which would be gratefully received.
Attention Crohn's patients in Christchurch, Wellington and Palmerston North
We need participants for a discussion group and are willing to pay you $60.
We are in in independent research/communications agency based in Wellington (GSL Promotus). We need people aged 18 years and over who have been diagnosed with Crohn's disease. It will be an informal discussion group with 6 other people with Crohn’s disease. The discussion will last up to 1.5 hours. We have been funded by AbbVie to help understand and look to improve health care experiences of people living with Crohn’s disease. So we need your help! The groups will be in Wellington on Tuesday 28th October, Palmerston North on Wednesday 29th October and Christchurch on Thursday 30th October from 6pm. If you are interested please text or phone Karlene Hazlewood on 0275728894 to find out more.
Dear Patients, Families and Supporters
It gives me pleasure to bring, to you, this Winter 2014 letter, to update you with the news since our last edition of our newsletter “Moving On. Here’s hoping that this finds you well, since our health is so critical to being able to live to the full!
This update aims to keep you informed about things that might help make life more liveable for people connected with inflammatory bowel disease, and to reduce the isolation that some patients can feel.
So this update is packed with information and tips which might help your health, or give you more options to discuss with your doctor or things to look forward to.
Click here to view our mid Winter 2014 letter.
Give Dad an Entertainment Book for Father's Day, and help our fundraising at the same time!
Thank you for your support!
A Guide for Patients with
There's now a new Patient Guide for patients with ulcerative colitis that enables you to record the details of your health on the same points-system as your medical team is likely to use and is called “How to complete your own Simple Clinical Colitis Activity Index”
The idea is that, before appointments, you can fill it in with the details about your symptoms that the medical team are likely to ask about. Or, if you think that your colitis is flaring up, you could fill it in at home to verify this and then, if you need to seek medical help, you have got the information that the medical team will need to be able to take care of you. Our thanks go to Dr Russell Walmsley of North Shore Hospital for his work on this.
Free Resource for women
From Surviving to Thriving - Top 5 health tips for women with IBD
Lana Vernon is a health coach and IBD patient on a mission to inspire women with Inflammatory Bowel Disease, not just to survive, but to thrive! She’s all about empowering you to take back control - helping you to rebuild your health and regain your life.
The e-book, titled 'From surviving to thriving', can be downloaded for free here.
Management of Inflammatory Bowel Disease
in Children and Adolescents in New Zealand
This document aims to provide an evidence-based guide to the diagnosis and management of Inflammatory Bowel Disease (IBD) in children and adolescents across New Zealand. The recommendations within this document provide a guide and may not encompass every clinical situation.The guideline is formulated within the framework of the Paediatric Gastroenterology Clinical Network.
Patient Journey Research: Results
What is it like to live with Inflammatory Bowel Disease
in New Zealand?
Atlantis Healthcare were asked by Janssen-Cilag (a pharmaceutical company) to talk to people living with IBD about their experiences.
Atlantis Healthcare talked to people living with IBD and the people who care for them – carers; gastroenterologists; nurses; a surgeon; a dietitian; and people from Crohn’s and Colitis New Zealand and the Ostomy Society
From this we tried to capture what it’s like to live with IBD from a medical; physical; psychological and social perspective
This is called a Patient Journey
The Autumn/Winter edition of our newsletter is here...
Dear Patients, Families and Supporters
It gives me pleasure to share with you our Autumn 2014 newsletter. Here’s hoping that this finds you well, since our health is so critical to being able to live to the full!
This newsletter aims to keep you informed about things that might help make life more liveable for people connected with inflammatory bowel disease, and to reduce the isolation that some patients can feel.
So this issue of our newsletter is packed with information and tips which might help your health, or give you more options to discuss with your doctor or things to look forward to. This includes our new 0800 number – 0800ASKIBD – see page 6.
Also, we are very proud to announce the holding of our first New Zealand camp for young people with inflammatory bowel disease next summer. Details are on the first couple of pages. Basically, the aim of the camp is to help young people to connect with others of their own age who have IBD, and to build confidence, independence, self-esteem, resilience and empowerment. We are really keen to hear from people who would like to come or help. The main funding is secure, thanks to the Ports of Auckland Fun Run last month, but we still need extra to make the camp a real success. So if you could donate, in cash or in kind, please do also contact us. Our email remains firstname.lastname@example.org , and a donation form is at the back of the newsletter.
Brian Poole, QSM
Chairman, Crohns & Colitis New Zealand
0800 ASK IBD
We are here to help!
CCNZ has just launched a new toll free (landline and mobile) 0800 Number for Crohn's & Colitis related enquiries. You can now call us from anywhere in NZ without the worry of how much the call is costing you.
We welcome you to leave us a message and we will get back to you as soon as possible (within 24 hours).
Call us on 0800 275 423.
Massey University - IBD Study
Massey University Researchers Hannah Morton (a nutrition PhD student) and Jane Coad (Associate Professor in Human Nutrition) are conducting a nationwide study of Inflammatory Bowel Disease (IBD). The aims of the study are to investigate the possible associations between environmental factors, foods, and vitamin D level in New Zealanders. Massey University would like to invite individuals with a confirmed IBD diagnosis, and healthy controls (who do not have IBD or a history of gastrointestinal complaints), who currently reside in New Zealand, to take part in this research study.
The Corticosteroids research survey is now closed.
Thank you so much for your participation. We will publish the results once Professor Gearry has completed his research.
We are what we eat
Research recently completed at Auckland University by Professor Lynn Ferguson, Head of Nutrition at the School of Medical Sciences, suggests that says the rate of chronic disease in New Zealand could be slashed just by changing our diets.
Professor Ferguson recently spoke to the Wellington Support Group - watch her presentation here.
The oral health research survey is now closed
Thank you so much for your participation. We will publish the results once Professor Nolan has completed her research.
News from Europe - EFCCA's latest magazine
the first issue of EFCCA magazine 2014 is now available. We hope you enjoy reading about the latest activities, news from members and other interesting articles related to IBD, including latest developments in the treatment of IBD.
Is there a therapeutic role for faecal microbiota transplantation in ulcerative colitis?
By: American Journal of Gastroenterology
September 5, 2012
Faecal microbiota therapy (FMT) is the transplanting of faecal bacteria from a healthy individual into a recipient. It is an emerging treatment for several gastrointestinal disorders. There are case reports of FMT successfully treating ulcerative colitis, according to researchers from the University of Washington-Seattle. The researchers suggest that FMT as a treatment for UC holds therapeutic potential and deserves further investigation.